Related Experiment Video
Updated: Feb 27, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.6K
Statins for children with familial hypercholesterolemia.
Alpo Vuorio1, Jaana Kuoppala, Petri T Kovanen
1Mehiläinen Airport Health Centre, Vantaa and Finnish Institute of Occupational Health, Lappeenranta, Finland.
The Cochrane Database of Systematic Reviews
|July 8, 2017
Summary
Statins effectively lower cholesterol in children with familial hypercholesterolemia, showing short-term safety. Long-term effects and safety require further study in pediatric lipid management.
Area of Science:
- Pediatric Cardiology
- Clinical Pharmacology
- Genetics
Background:
- Familial hypercholesterolemia (FH) is a common inherited metabolic disorder affecting at least 1 in 500 individuals.
- Early diagnosis and lifelong treatment are crucial due to premature atherosclerosis and cardiovascular disease risk.
- Dietary changes and lipid-lowering medications are key treatments for children with FH.
Purpose of the Study:
- To evaluate the effectiveness and safety of statin therapy in children diagnosed with heterozygous familial hypercholesterolemia.
- To assess the impact of statins on lipid levels and cardiovascular risk markers in pediatric patients.
Main Methods:
- Systematic review of randomized controlled trials involving children up to 18 years old.
- Comparison of statin treatment versus placebo or diet alone.
- Data extraction and analysis by two independent researchers.
Main Results:
- Nine randomized placebo-controlled studies with 1177 participants were included.
- Statins significantly reduced low-density lipoprotein cholesterol levels (moderate quality evidence).
- No significant differences in liver enzymes or creatine kinase; risks of myopathy and adverse events were low.
Conclusions:
- Statin therapy is effective for lipid reduction in children with FH, with good short-term safety.
- Long-term safety of statins in this pediatric population remains undetermined.
- Further long-term randomized controlled trials are necessary to establish definitive safety profiles.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:29Cholesterol: Significance and Regulation
1.7K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.7K
01:26Atherosclerosis III: Management
512
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512
01:18Lipids: Dietary Sources and Requirements
2.4K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.4K
01:29Pharmacogenomics: Identification of New Drug Targets
49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289